Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Tretinoin × 1 year × Clear all

Sponsor

Conditions

Leukemia, Promyelocytic, Acute 3 Neoplasm Metastasis 2 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Oligometastatic Disease 1 Oligodendroglioma 1 Multiple Myeloma 1 Melanoma 1 Lung Neoplasms 1 Leukemia 1 Leiomyosarcoma 1 HER2 Negative Breast Cancer 1 Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasm Female 1 Astrocytoma 1

Interventions

lutetium Lu 177 dotatate 18 Magnetic Resonance Spectroscopy 10 Everolimus 8 pembrolizumab 7 Specimen Handling 7 Nivolumab 6 Capecitabine 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 surufatinib 4 cabozantinib 4 amino-acid, glucose, and electrolyte solution 4 Octreotide 4 lenvatinib 3 gallium Ga 68 dotatate 3 Temozolomide 3 Ipilimumab 3 Injections 3 Fluorodeoxyglucose F18 3 Cyclophosphamide 3 tislelizumab 2 olaparib 2 lanreotide 2 fludarabine phosphate 2 fludarabine 2 atezolizumab 2 X-Rays 2 Surveys and Questionnaires 2 Phantoms, Imaging 2 PM 01183 2 FAPI-46 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡